Cardiovascular Manifestations of COVID-19: Insights into a Single-Center Experience
Background Since December 2019, an emerging outbreak of novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2). The aim of the present report is to describe a population with elevated levels of high-sensitive cardiac troponin T (hs-cTn...
Main Authors: | Sara Schukraft, Jean-Luc Magnin, Stéphane Cook |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2021-07-01
|
Series: | TH Open |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731775 |
Similar Items
-
Cardiovascular manifestations and outcomes in patients admitted with severe COVID-19: Middle Eastern Country multicenter data
by: Fahad Alkindi, et al.
Published: (2021-01-01) -
Biomarkers in predicting cardiovascular risk: new prospects of troponin I
by: A. V. Kontsevaya, et al.
Published: (2020-07-01) -
Cardiovascular Abnormalities Among Patients with Spontaneous Subarachnoid Hemorrhage. A Single Center Experience
by: Akram Y. Elgendy, MD, MRCP, et al.
Published: (2016-05-01) -
Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool
by: Sara Momtazmanesh, et al.
Published: (2020-07-01) -
Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients—Results from the CORONA Germany Study
by: Melanie A. Gunawardene, et al.
Published: (2021-09-01)